|
|
|
|
|
|
Top Selling U.S. Medications List |
Medical
Summaries |
||
|
Here is a
summary of 2008 U.S. prescription drug sales, for the 30 top
selling drugs, compared with 2003, 2004, 2005, 2006 and 2007
U.S. drug sales. |
|||
|
30 |
640-980 |
30 |
260 |
|
2003, 2004, 2005, 2006, 2007 and 2008 Top U.S. Prescription Drug Sales List - Comparison Chart |
||||||||||
|
Sales Rank |
Sales Rank |
Sales Rank |
Sales Rank |
Sales Rank |
Sales Rank |
Drugs Listed |
2006 World-Wide Sales |
Primary Use |
Company |
. |
|
1 |
|
|
|
|
|
Lipitor |
$ 14,385 M |
cholesterol (1,367) |
Pfizer |
New York, NY |
|
5 |
4 |
|
|
|
|
Nexium |
$ 5,182 M |
heartburn |
AstraZeneca |
London, Eng. |
|
|
8 |
|
|
|
4 |
Advair Diskus |
$ 6,129 M |
asthma |
GlaxoSmithKline |
London, Eng. |
|
3 |
3 |
|
|
|
5 |
Prevacid |
$ 3,425 M |
heartburn |
TAP Pharma |
Lake Forest, IL |
|
|
7 |
|
|
|
|
Plavix |
$ 6,057 M |
anticoagulant |
Bristol-Myers Squibb |
New York, NY |
|
|
|
|
|
|
7 |
Singulair |
$ 3,579 M |
asthma - (2,426) |
Merck |
Whitehouse Station, NJ |
|
|
|
|
|
|
6 |
Seroquel |
$ 3,560 M |
depression - (148) |
AstraZeneca |
London, Eng. |
|
|
|
|
|
|
8 |
Effexor |
$ 3,722 M |
depression |
Wyeth |
Madison, NJ |
|
|
|
|
|
|
9 |
Oxycontin |
- |
pain |
Purdue Pharma |
Stamford, CT |
|
55 |
|
|
|
|
11 |
Lexapro |
$ 2,696 M |
depression |
Forest Labs. |
Commack, NY |
|
|
|
|
|
|
10 |
Actos |
$ 2,880 M |
diabetes |
Takeda Pharma. |
Osaka, Japan |
|
|
|
|
|
|
68 |
Protonix |
$ 3,621 M |
heartburn |
Wyeth |
Madison, NJ |
|
>200 |
>200 |
|
|
|
18 |
Vytorin |
$ 1,955 M |
cholesterol |
Merck |
Whitehouse Station, NJ |
|
|
|
|
|
|
13 |
Topamax |
$ 2,027 M |
migraine - (679) |
Johnson & Johnson |
New Brunswick, NJ |
|
|
|
|
|
|
28 |
Risperdal |
$ 4,183 M |
schizophrenia |
Johnson & Johnson |
New Brunswick, NJ |
|
111 |
|
|
|
|
12 |
Abilify |
$ 1,900 M |
schizophrenia |
Otsuka Pharma. |
Tokushima, Japan |
|
>200 |
>200 |
|
|
|
14 |
Cymbalta |
$ 1,316 M |
depression |
Eli Lilly |
Indianapolis, IN |
|
75 |
|
|
|
|
19 |
Lamictal |
$ 1,843 M |
epilepsy - (322) |
GlaxoSmithKline |
London, Eng. |
|
6 |
9 |
|
|
|
15 |
Zyprexa |
$ 4,364 M |
schizophrenia |
Eli Lilly |
Indianapolis, IN |
|
|
|
|
|
|
22 |
Levaquin |
$ 1, 530 M |
antibiotic - (2,358) |
Johnson & Johnson |
New Brunswick, NJ |
|
8 |
10 |
|
|
|
20 |
Celebrex |
$ 2,039 M |
arthritis |
Pfizer |
New York, NY |
|
126 |
|
|
|
|
30 |
Zetia |
$ 1, 929 M |
cholesterol |
Merck |
Whitehouse Station, NJ |
|
72 |
|
|
|
|
16 |
Valtrex |
$ 1,563 M |
herpes |
GlaxoSmithKline |
London, Eng. |
|
>200 |
|
|
|
|
17 |
Crestor |
$ 2,049 M |
cholesterol |
AstraZeneca |
London, Eng. |
|
|
|
|
|
|
133 |
Fosamax |
$ 3,134 M |
osteoporosis (155) |
Merck |
Whitehouse Station, NJ |
|
|
|
|
|
|
>200 |
Zyrtec |
$ 2,377 M |
allergy |
Pfizer |
New York, NY |
|
109 |
|
|
|
|
21 |
Lantus |
$ 2,093 M |
diabetes |
Sanofi-Aventis |
Paris, France |
|
90 |
|
|
|
|
23 |
Adderall XR |
$ 864 M |
amphetamine |
Shire Pharma. |
Hampshire, Eng. |
|
>200 |
>200 |
>200 |
|
|
24 |
Lyrica |
- |
antiseizure |
Pfizer |
New York, NY |
|
65 |
|
|
|
|
25 |
Diovan |
$ 4,223 M |
hypertension (100) |
Novartis |
Basel, Swit. |
|
|
|
|
|
|
76 |
Avandia |
$ 3,043 M |
diabetes |
GlaxoSmithKline |
London, Eng. |
|
79 |
|
|
|
|
26 |
Tricor |
$ 1,567 M |
cholesterol |
Abbott Labs. |
Abbott Park, IL |
|
|
|
|
|
|
27 |
Flomax |
- |
urinary - (120) |
Boehringer-Ingelheim |
Ingleheim, Ger. |
|
|
|
|
|
|
29 |
Diovan HCT |
- |
hypertension |
Novartis |
Basel, Swit. |
|
|
|
|
|
|
|
- |
||||
|
>200 |
>200 |
>200 |
|
41 |
>200 |
Ambian |
$ 2,545 M |
insomnia - (166) |
Sanofi-Aventis |
Paris, France |
|
|
|
|
|
46 |
48 |
Enbrel |
$ 4,379 M |
arthritis |
Wyeth |
Madison, NJ |
|
>200 |
>200 |
>200 |
|
47 |
32 |
Spiriva |
$ 1,735 M |
bronchospasm |
Boehringer-Ingelheim |
Ingleheim, Ger. |
|
|
|
10 |
9 |
52 |
>200 |
Norvasc |
$ 4,866 M |
hypertension - Pfizer |
These drugs fell into disfavor in 2007. |
|
|
68 |
|
|
|
59 |
54 |
Cozaar/ Hyzaar |
$ 3,163 M |
hypertension - Merck |
||
|
|
|
|
|
53 |
40 |
Lovenox |
$ 3,059 M |
anticoagulant - Sanofi |
||
|
160 |
148 |
115 |
|
99 |
87 |
Gleevec/ Glivec |
$ 2,554 M |
leukemia - Novartis |
||
|
4 |
5 |
|
|
105 |
118 |
Procrit |
$ 3,180 M |
anemia - J&J |
||
|
>200 |
|
|
|
|
109 |
Yasmin 28 |
- |
birth control (4,799) |
||
|
>200 |
|
|
|
162 |
85 |
Humira |
$ 2,044 M |
arthritis - Abbott |
||
|
7 |
6 |
6 |
|
170 |
>200 |
$ 2,110 M |
depression - Pfizer (271) |
|||
|
2 |
2 |
4 |
8 |
>200 |
>200 |
$ 2,803 M |
cholesterol - Merck (487) |
These drugs have fallen off the
map. |
||
|
|
|
>200 |
>200 |
>200 |
>200 |
$ 4,428 M |
Crohn's Disease - J&J |
|||
|
|
|
187 |
|
>200 |
>200 |
$ 4,121 M |
anemia - Amgen |
|||
|
|
|
>200 |
>200 |
>200 |
>200 |
MabThera/ Rituxan |
$ 3,861 M |
cancer - Genentech |
||
|
120 |
|
>200 |
>200 |
>200 |
>200 |
Herceptin |
$ 3,134 M |
breast cancer - Roche |
||
|
|
|
>200 |
>200 |
>200 |
>200 |
$ 2,710 M |
chemotherapy - Amgen |
|||
|
9 |
|
>200 |
>200 |
>200 |
>200 |
$ 2,511 M |
anemia - Amgen |
|||
|
>200 |
183 |
>200 |
>200 |
>200 |
>200 |
Avastin |
$ 2,364 M |
cancer - Roche |
||
|
|
|
>200 |
>200 |
>200 |
>200 |
Prevnar |
$ 1,961 M |
vaccine - Wyeth |
||
|
10 |
|
123 |
>200 |
>200 |
>200 |
Neurontin |
- |
seizures - Pfizer |
||
|
|
|
|
|
>200 |
>200 |
Pravachol |
- |
cholesterol - Bristol-M. |
||
|
|
|
|
|
>200 |
128 |
Duragesic |
- |
pain - Janssen |
||
|
|
124 |
147 |
159 |
>200 |
>200 |
Prilosec |
- |
heartburn - Astrazenica |
||
|
|
|
|
105 |
>200 |
>200 |
Paxil |
- |
depression - GSK (188) |
||
|
|
|
>200 |
>200 |
>200 |
>200 |
Vioxx |
- |
pain - Merck |
||
|
158 |
149 |
>200 |
>200 |
>200 |
>200 |
lisinopril |
- |
hypertension - |
||
|
>200 |
>200 |
>200 |
>200 |
>200 |
>200 |
Mirena |
- |
birth control (3,398) |
||
|
|
|
|
|
|
|
|
|
(xxx) above refers to
the number of side effect complaints at |
||
|
Red = Sales drop from
previous year |
2003 Data
Source: http://www.drugs.com/top200_2003.html |
|||||||||
|
50 |
50 |
50 |
50 |
50 |
|
120 |
90 |
150 |
130 |
170 |
|
Disclaimer |
|
Vaughn's Summaries (One-Pagers) Webmaster: Vaughn Aubuchon ©2009 - All Rights Reserved This Vaughns Top Prescription Drug Sales Summary Chart web page was updated on 2010-03-15. |